Article

Pathological response after chemoradiation for T3 rectal cancer

Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA.
Colorectal Disease (Impact Factor: 2.02). 07/2009; 12(7 Online):e24-30. DOI: 10.1111/j.1463-1318.2009.02013.x
Source: PubMed

ABSTRACT The aim of this study was to investigate the effect of preoperative chemoradiotherapy (CRT) on nodal disease in locally advanced rectal adenocarcinoma.
Thirty-two patients staged uT3N0 and 27 patients staged uT3N1 rectal adenocarcinoma who underwent pre-CRT staging using endoscopic ultrasound or rectal protocol CT were included. The median radiation dose was 50.4 Gy (range: 45-50.4 Gy) at 1.8 Gy per fraction and all patients received concurrent 5-FU or capecitabine-based chemotherapy. Low anterior resection or abdomino-perineal resection occurred at a median of 46 days (range: 27-112 days) after CRT.
Eleven of 32 uT3N0 patients (34.4%) and 13 of 26 uT3N1 patients (50.0%) had ypN+ (P = 0.29). For patients with uT3N0, 10 of 20 (50.0%) with ypT2-3 and 1 of 12 (8.3%) with ypT0-1 were ypN+ (P = 0.02). For patients with uT3N1, 12 of 20 (60.0%) with ypT2-3 and 1 of 6 (16.7%) with ypT0-1 were ypN+ (P = 0.16). Overall, the ypN+ rate was 11.1% in the ypT0-yT1 group compared with 55.0% in the ypT2-yT3 group (P = 003). Among patients with uT3N0 disease, the ypN+ rate in patients who had surgery > 46 days vs<or= 46 days was 7.1%vs 55.6% (P = 0.01) respectively. Among patients with uT3N1 disease, the ypN+ rate in patients who had surgery > 46 days vs<or= 46 days was 54.5%vs 46.7%, (P = 0.99) respectively. Overall, the ypN+ rate in patients who had surgery > 46 days vs<or= 46 days was 28.0%vs 51.5% (P = 0.11).
The risk of residual nodal disease after CRT is significant. Primary tumour response is associated with nodal response.

1 Bookmark
 · 
211 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: : After the impressive response of rectal cancers to neoadjuvant therapy, it seems reasonable to ask: can we can excise the small ulcer locally or avoid a radical resection if there is no gross residual tumor? Does gross response reflect what happens to tumor cells microscopically after radiation? : The aim of this study was to identify microscopic tumor cell response to radiation. : This study is a retrospective review of a prospectively collected database. : This investigation was conducted at a single tertiary medical center. : Patients were selected who had elective radical resection for rectal cancer after preoperative chemotherapy and radiation performed by 2 colorectal surgeons between 2006 and 2011. : The primary outcome measured was tumor presence after radiation therapy : Of the 75 patients, 20 patients were complete responders and 55 had residual cancer. Of these patients, 28 had no tumor cells seen outside the gross ulcer, and 27 (49.1%) had tumor outside the visible ulcer or microscopic tumor present with no overlying ulcer. Of these tumors, 81.5% were skewed away from the ulcer center. The mean distance of distal scatter was 1.0 cm from the visible ulcer edge to a maximum of 3 cm; 3 patients had tumor cells more than 2 cm distal to the visible ulcer edge. Tumor scatter outside the ulcer was not associated with poor prognostic factors, such as nodal and distant disease, perineural invasion, or mucin; however, it was associated with lymphovascular invasion (χ2 = 4.12, p = 0.038) : There was limited access to clinical information gathered outside our institution. : Our study suggests that 1) after radiation, the gross ulcer cannot be used to determine the sole area of potential residual tumor, 2) cancer cells may be found up to 3 cm distally from the gross ulcer, so the traditional 2-cm margin may not be adequate, and 3) local excision of the ulcer or no excision after apparent complete response appears to be insufficient treatment for rectal cancer.
    Diseases of the Colon & Rectum 12/2012; 55(12):1206-12. DOI:10.1097/DCR.0b013e318269fdb3 · 3.20 Impact Factor